Patent Assignment
Reel/Frame 029277/0286
Change of Name
Recorded: 2012-11-11
Pages: 65
Assignor
BAYER SCHERING PHARMA AKTIENGESELLSCHAFT
Executed: 2011-07-01
Assignee
BAYER PHARMA AKTIENGESELLSCHAFT
MUELLERSTRASSE 178, BERLIN, 13353, GERMANY
Covered Properties
(103)
Amide Complexes
Patent:
5,693,310 →
Application:
07/614,947 →
1,4,7,10-Tetraazacyclododecane Butyltriols, Processes for Their Production and Pharmaceutical Agents Containing Them
Patent:
5,980,864 →
Application:
07/671,041 →
Process for the Production of N-Beta-Hydroxyalkyl-Tri-N-Carboxyalkyl- 1,4,7,10-Tetraazacyclododecane and N-Beta-Hydroxyalkyl-Tri-N- Carboxyalkyl-1,4,8,11-Tetraazacyclotetradecane Derivatives and Their Metal Complexes
Patent:
5,386,028 →
Application:
08/016,452 →
Ultrasonic Processes and Circuits for Performing Them
Patent:
5,410,516 →
Application:
08/076,221 →
Process for the Production of Mono-N-Substituted Tetraaza Macrocycles
Patent:
5,410,043 →
Application:
08/141,445 →
Macrocyclic Compounds as Complexing Compounds or Agents Complexes of Metal Ions Therewith and Use Thereof as Contrast Media for Diagnos- Tics and Therapeutics
Patent:
5,871,709 →
Application:
08/179,552 →
Dtpa Monoamides, Pharmaceutical Agents Containing These Compounds, Their Use and Process for Their Production
Patent:
5,859,214 →
Application:
08/228,524 →
Polymer-Bonded Complexing Agents and Pharmaceutical Agents Containing Them for MR1
Patent:
5,681,543 →
Application:
08/289,341 →
Derivatized Dtpa Complexes, Pharmaceutical Agents Containing These Compounds, Their Use, and Processes for Their Production
Patent:
6,039,931 →
Application:
08/319,357 →
Ultrasonic Processes and Circuits for Carrying Out Those Processes
Patent:
5,678,553 →
Application:
08/332,746 →
Derivatized Dtpa Complexes, Pharmaceutical Agents Containing These Compounds, Their Use, and Processes for Their Production
Patent:
5,695,739 →
Application:
08/351,126 →
Gestodene-Containing Agent for Transdermal Administration
Patent:
5,788,984 →
Application:
08/403,137 →
Transdermal Therapeutic Systems with Crystallization Inhibitors
Patent:
5,676,968 →
Application:
08/433,557 →
Plasminogen Activator from Saliva of the Vampire Bat
Patent:
6,008,019 →
Application:
08/456,833 →
Derivatized Dtpa Complexes Pharmaceutical Agents Containing These Compounds, Their Use, and Processes for Their Production
Patent:
5,798,092 →
Application:
08/461,746 →
Method of Enhancing Paramagnetism in Chelates for Mri
Patent:
5,560,903 →
Application:
08/462,681 →
Ultrasonic Processes and Circuits for Performing Them
Patent:
6,064,628 →
Application:
08/467,886 →
Vampire Bat Salivary Plasminogen Activators
Patent:
5,830,849 →
Application:
08/467,966 →
Polymer-Bonded Complexing Agents, Their Complexes and Conjugates, Processes for Their Production and Pharmaceutical Agents Containing Them
Patent:
5,681,544 →
Application:
08/484,308 →
Dtpa Monoamides, Pharamceutical Agents Containing These Compounds, Their Use and Process for Their Production
Patent:
5,843,399 →
Application:
08/484,317 →
Process for the Production of C-Substituted Diethylenetriamines
Patent:
5,654,467 →
Application:
08/495,474 →
Combination Contraceptive
Patent:
6,225,297 →
Application:
08/666,592 →
Combination Compound for Contraception Based on Natural Estrogen
Patent:
6,133,251 →
Application:
08/738,314 →
A Method for Treating Endometriosis or Leimyomata Uteri with a Competitive Progesterone Antagonist and a Gestagen
Patent:
6,043,234 →
Application:
08/776,152 →
Process for the Production of 1,4,7,10-Tetraazacyclododecane and Its Derivatives
Patent:
5,744,616 →
Application:
08/805,585 →
Adapter for Extracting a Liquid from a Container Closed with a Stopper
Patent:
6,039,093 →
Application:
09/051,791 →
Process for Mono- and 1,7-Bis-N-Beta-Hydroxyalkylation of Cyclene; N-Beta-Hydroxyalkyl-1,4,7,10-Tetraazacyclododecane-Lithium-Salt Complexes and the Use of the Complexes for the Production of Gadobutrol and Analogs
Patent:
5,994,536 →
Application:
09/088,700 →
Process for the Production of Cyclene
Patent:
6,156,890 →
Application:
09/451,702 →
Progesterone Antagonists for the Production of Pharmaceutical Agents for the Treatment of Dysfunctional Uterine Bleeding
Patent:
6,451,780 →
Application:
09/615,060 →
Syringe with a Barrel Having a Sealing Cap to Hold a Fluid Medium Within the Barrel
Combination Preparation for Contraception Based on Naural Estrogens
Method for in Vitro Diagnosis of Endometriosis
6-Alkenyl-, 6-Alkinyl-and 6-Epoxy-Epothilone Derivatives, Process for Their Production, and Their Use in Pharmaceutical Preparations
Patent:
7,125,893 →
Application:
09/979,939 →
Lithium Complexes of N-(1-Hydroxymethyl-2,3-Dihydroxypropyl)-1,4,7-Triscarboxymethyl-1,4,7,10-Tetraazacyclododecane, Their Production and Use
8 Beta-Hydrocarbyl-Substituted Estratrienes for Use as Selective Estrogens
17ALPHA-Alkyl-17BETA-Oxy-Estratrienes and Intermediate Products for Their Production, Use of the 17ALPHA-Alkyl-17BETA-Oxy-Estratrienes for the Production of Pharmaceutical Agents as Well as Pharmaceutical Preparations
Process for the Overexpression of Dehydrogenases
9-Alpha-Substituted Estratrienes as Selectively Active Estrogens
Uv Stable Transdermal Therapeutic Plaster with a Uv Absorbing Adhesive Layer Separated from the Drug Matrix
Vegfr-2 and Vegfr-3 Inhibitory Anthranilamide Pyridines
6-Alkenyl-, 6-Alkinyl- and 6-Epoxy-Epothilone Derivatives, Process for Their Production, and Their Use in Pharmaceutical Preparations
Sulfoximine-Substituted Pyrimidines as Cdk-and/or Vegf Inhibitors, Their Production and Use as Pharmaceutical Agents
17ALPHA-Alkyl-17BETA-Oxy-Estratrienes and Intermediate Products for Their Production, Use of the 17ALPHA-Alkyl-17BETA-Oxy-Estratrienes for the Production of Pharmaceutical Agents as Well as Pharmaceutical Preparations
Method for treatment of dysmenorrhea
1-Phenyl-2-Heteroaryl-Substituted Benzimidazole Derivatives, Their Use for the Production of Pharmaceutical Agents as Well as Pharmaceutical Preparations That Contain These Derivatives
6-Alkenyl -, 6-Alkinyl- and 6-Epoxy-Epothilone Derivatives, Process for Their Production, and Their Use in Pharmaceutical Preparations
Novel Nicotinamide Pyridinureas as Vascular Endothelial Growth Factor (Vegf) Receptor Kinase Inhibitors
Novel Anthranilamide Pyridinureas as Vascular Endothelial Growth Factor (Vegf) Receptor Kinase Inhibitors
Novel Anthranilamide Pyridinureas as Vascular Endothelial Growth Factor (Vegf) Receptor Kinase Inhibitors
1,2 Diarylbenzimidazoles and Their Pharmaceutical Use
3-Amino-Pyrazolo[3,4B]Pyridines as Inhibitors of Protein Tyrosine Kinases, Their Production and Use as Pharmaceutical Agents
1,2 Diarylbenzimidazoles and Their Pharmaceutical Use
18-Methyl-19-nor-17-pregn-4-ene-21,17-carbolactones, as well as pharmaceutical preparations that contain the latter
Decomposer film for transdermal patches
Application:
11/327,823 →
Publication:
US 2007/0014839
Pyrazolopyridines and Salts Thereof, a Pharmaceutical Composition Comprising Said Compounds, a Method of Preparing Same and Use of Same
Multi-layered transdermal system with triazine UV absorber
Gripping Edge for a Syringe with Improved Protection Against Bursting
Intermediates for the Preparation of Lipoxin A4 Analogs
Intermediates for the Preparation of Lipoxin A4 Analogs
Process for Recovery of Iopromide, Suitable for Pharmaceutical Purposes, from Mother Liquors
Sulfoximine-Substituted Pyrimidines, Processes for Production Thereof and Use Thereof as Drugs
Tamper-Proof Closure
Application:
11/719,462 →
Publication:
US 2009/0283493
Sulphimides as Protein Kinase Inhibitors
Substituted Arylpyrazolopyridines and Salts Thereof, Pharmaceutical Compositions Comprising Same, Methods of Preparing Same and Uses of Same
Substituted Aminopyrazolopyridines and Salts Thereof, Pharmaceutical Compositions Comprising Same, Methods of Preparing Same and Uses of Same
Substituted Pyrazolopyridines and Salts Thereof, Pharmaceutical Compositions Comprising Same, Methods of Preparing Same and Uses of Same
18-Methyl-19-Norandrost-4-Ene 17, 17-Spiro Ether (18-Methyl-19-nor-20-Spirox-4-En-3-One), and Pharmaceutical Products Comprising the Same
Substituted Sulphoximines as TIE2 Inhibitors and Salts Thereof, Pharmaceutical Compositions Comprising Same, Methods of Preparing Same and Uses of Same
Method for preparing 4-[17beta-methoxy-17alpha-methoxymethyl-3-oxestra-4,9-dien-11beta-yl]benzaldehyde (E)-oxime (asoprisnil)
Application:
11/785,421 →
Publication:
US 2009/0054387
Use of Estradiol Valerate or 17BETA-Estradiol in Combination with Dienogest for Oral Therapy to Maintain and/or Increase Feminine Libido
Metal Chelates Having a Perfluorinated Peg Radical, Processes for Their Preparation, and Their Use
Progesterone Receptor Antagonists
Drospirenone Containing Transdermal Drug Delivery Devices and Methods of Delivery Thereof
Application:
11/995,767 →
Publication:
US 2009/0181075
Crystalline Potassium Salt of Lipoxin A4 Analogs
Closure Piece for Medical Syringe
17BETA-Cyano-19-Nor-Androst-4-Ene Derivative, Its Use and Medicaments Comprising the Derivative
17BETA-Cyano-18A-Homo-19-Nor-Androst-4-Ene Derivative, Its Use and Medicaments Comprising the Derivative
Application:
12/137,122 →
Publication:
US 2009/0048218
Sulphoximine-Substituted Quinazoline Derivatives as Immuno-Modulators, Their Preparation and Use as Medicaments
Process for the Preparation of 17-(3-Hydroxypropyl)-17-Hydroxysteroids
Substituted Pyrimidine Derivatives Useful in the Treatment of Cancer and Other Disorders
8-Beta-Substituted Estratrienes as Selectively Active Estrogens
Application:
12/171,424 →
Publication:
US 2009/0029957
Device and Use for Storage and Provision of Medicament Wafers
Fused Bicyclic Pyrimidines
Novel 2-Substituted Thiazole-4-Carboxamide Derivatives, Their Preparation and Use as Pharmaceuticals
Novel 2-Hetarylthiazole-4-Carboxamide Derivatives, Their Preparation and Use as Pharmaceuticals
Fused Azole-Pyrimidine Derivatives
Mineralcorticoid Receptor Antagonists for the Treatment of Endometriosis
Application:
12/529,447 →
Publication:
US 2011/0003778
17BETA-Cyano-19-Androst-4-Ene Derivative, Its Use and Medicaments Comprising the Derivative
Application:
12/664,099 →
Publication:
US 2010/0292184
11B-Fluoro-3-Acetoxyestra-3,5-Dien-17-One and Method for the Production Thereof
Application:
12/739,195 →
Publication:
US 2011/0009654
15, 16-Methylene-17-(1'-Propenyl)-17,3'-Oxidoestra-4-En-3-One Derivative , Use Thereof, and Medicament Containing Said Derivative
17-(1'PROPENYL)-17-3'-Oxidoestra-4-En-3-One Derivative, Use Thereof, and Medicament Containing Said Derivative
19-Nor-Steroid Derivatives with a 15ALPHA, 16ALPHA-Methylene Group and a Saturated 17, 17-Spiro-Lactone Ring, Use Thereof, and Medicaments Containing Said Derivatives
Application:
12/810,860 →
Publication:
US 2010/0311702
17-Hydroxy-19-Nor-21-Carboxylic Acid-Steroid Y-Lactone Derivative, Use Thereof, and Medicament Containing the Derivative
15,16-Methylene-17-hydroxy-19-nor-21-carboxylic acid-steroid Y-lactone derivative, use thereof and medicinal products containing the derivative
Application:
12/811,002 →
Publication:
US 2011/0015162
Graphical User Interface
Drug Delivery System with Stabilising Effect
Application:
12/867,165 →
Publication:
US 2011/0052699
Pharmaceutical Preparation Containing a Gestagen, and Kit and Method for Treating Endometriosis Using the Preparation
Application:
12/885,919 →
Publication:
US 2011/0008409
Method for Preparing 4-[17BETA-Methoxy-17ALPHA-Methoxymethyl-3-Oxoestra-4,9-Dien-11-Beta-Yl]Benzaldehyde (E)-Oxime (Asoprisnil)
C-ring-substituted pregn-4-ene-21,17-carbolactones, and pharmaceutical preparations comprising the same
Application:
12/995,475 →
Publication:
US 2011/0130371
Crystalline Potassium Salt of Lipoxin A4 Analogs
Drug Delivery System
Application:
13/130,326 →
Publication:
US 2012/0282340
Process for Preparing Epothilone Derivatives by Selective Catalytic Epoxidation
Hormone Replacement Therapy and Depression
Application:
13/411,131 →
Publication:
US 2012/0225853
Related Assignments
(6)
Other recorded transfers of the patents in this record — the chain of ownership.
Change of Name
Jul 1, 2013
From: BAYER PHARMA AKTIENGESELLSCHAFT
To: BAYER INTELLECTUAL PROPERTY GMBH
Reel/Frame 030719/0150 →
Change of Name
Jul 1, 2013
From: BAYER PHARMA AKTIENGESELLSCHAFT
To: BAYER INTELLECTUAL PROPERTY GMBH
Reel/Frame 030719/0390 →
Change of Name
Jul 1, 2013
From: BAYER PHARMA AKTIENGESELLSCHAFT
To: BAYER INTELLECTUAL PROPERTY GMBH
Reel/Frame 030719/0474 →
Change of Name
Jul 1, 2013
From: BAYER PHARMA AKTIENGESELLSCHAFT
To: BAYER INTELLECTUAL PROPERTY GMBH
Reel/Frame 030719/0529 →
Change of Name
Jul 1, 2013
From: BAYER PHARMA AKTIENGESELLSCHAFT
To: BAYER INTELLECTUAL PROPERTY GMBH
Reel/Frame 030719/0668 →
Change of Name
Aug 26, 2016
From: BAYER PHARMA AKTIENGESELLSCHAFT
To: BAYER INTELLECTUAL PROPERTY GMBH
Reel/Frame 039550/0557 →